Ryan W. Huey

Hematology

13900 Katy Fwy Fl 3
Houston, TX 77079

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy.

Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy.

Journal: The oncologist

Published: March 02, 2026

Dissonance in the Sole Quality Measure for Outpatient Chemotherapy, OP-35.

Dissonance in the Sole Quality Measure for Outpatient Chemotherapy, OP-35.

Journal: JCO clinical cancer informatics

Published: December 22, 2025

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma.

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma.

Journal: The oncologist

Published: September 29, 2025

Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer.

Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer.

Journal: The oncologist

Published: July 24, 2025

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT.

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT.

Journal: JCO precision oncology

Published: July 16, 2025

Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences.

Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: June 17, 2025

Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and Outcomes.

Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and Outcomes.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 29, 2025

CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract Cancer.

CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.

Journal: Journal of hematology & oncology

Published: February 19, 2025

Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer.

Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer.

Journal: Cancers

Published: January 09, 2025

Mutational and co-mutational landscape of early onset colorectal cancer.

Mutational and co-mutational landscape of early onset colorectal cancer.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: January 06, 2025

The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer.

The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer.

Journal: Cancers

Published: December 05, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026